E-ISSN: 2667-4610
Download Issue
Archives
Volume 12, Issue 4
December 2013
Back to Archives
Download Issue
Editorial
1
Bph
8
Quality Of Life
3
Pathology
2
General
1
Editorial
Editorial
Güven Aslan
Bph
Metabolic syndrome in the etiology of benign prostatic hyperplasia/ lower urinary tract symptoms
Polat Türker
Cenk M. Yazıcı
Quick View
The current status of prostate-specific antigen in the management of Benign Prostatic Hyperplasia
Ali Tekin
Quick View
Urodynamic studies in Benign Prostate Hyperplasia: whom and when?
Umut Gönülalan
Murat Koşan
Quick View
The role of phosphodiesterase type-5 inhibitors in Benign Prostatic Hyperplasia, current approaches
Eray Kemahlı
Adnan Gücük
Uğur Üyetürk
Quick View
Prostatic inflammation as a target of etiopathogenesis and treatment
Murat Koşan
Umut Gönülalan
Quick View
The combination of anticholinergics and alpha-1 receptor blockers
Yusuf Şenoğlu
Kamil Çam
Quick View
Will lasers replace transurethral resection of the prostate for the treatment of BPH?
Ali Erol
Serhat Dönmezer
Erem Kaan Başok
Quick View
Long-term treatment of Benign Prostatic Hyperplasia with the combination of alpha blockers and 5-alpha reductase inhibitors
Cevahir Özer
Mehmet İlteriş Tekin
Quick View
Quality Of Life
The impact of control cystoscopies' on quality of life in the surveillance of bladder tumor
İlker Çelen
Quick View
The comparison of the treatment alternatives on quality of life in testicular cancers
Sinharib Çitgez
Çetin Demirdağ
Kamil Çam
Quick View
Does laser prostatectomy provide an advantage regarding quality of life?
Olcay Yıldırım
Kamil Çam
Quick View
Pathology
Prostate cancer: New developments in pathogenesis and prognostic repercussions
Bora Gürel
Quick View
Evaluation of the non-neoplastic kidney in tumor nephrectomy specimens and its significance
Ayşim Özağarı
Quick View
General
Basic molecular methods used in urooncology
Bora İrer
Güven Aslan
Quick View
Reviewers
Review
Article
Reviewer
Corner
Authors
Submit
Article
Author
Corner
Journal Metrics
Clarivate Current Impact Factor: 0.1
Clarivate 5 Year Impact Factor: 0.1
Journal Information
Date of Foundation
Mar 2002
Abbreviation
Bull Urooncol
Last Issue
Editorial Board
Abstract in Index
Journal History
Forms
Permission Request Form
Copyright Agreement Form
Acknowledgements Form
Useful Links
ICMJE Recommendations
Crossref Similarity Check
ICMJE Conflict of Interest Disclosure Form
EndNote